Objective-Obesity is characterized by chronic inflammation of adipose tissue, which contributes to insulin resistance and diabetes. Although nitric oxide (NO) signaling has antiinflammatory effects in the vasculature, whether reduced NO contributes to adipose tissue inflammation is unknown. We sought to determine whether (1) obesity induced by high-fat (HF) diet reduces endothelial nitric oxide signaling in adipose tissue, (2) reduced endothelial nitric oxide synthase (eNOS) signaling is sufficient to induce adipose tissue inflammation independent of diet, and (3) increased cGMP signaling can block adipose tissue inflammation induced by HF feeding. Methods and Results-Relative to mice fed a low-fat diet, an HF diet markedly reduced phospho-eNOS and phospho-vasodilator-stimulated phosphoprotein (phospho-VASP), markers of vascular NO signaling. Expression of proinflammatory cytokines was increased in adipose tissue of eNOSϪ/Ϫ mice. Conversely, enhancement of signaling downstream of NO by phosphodiesterase-5 inhibition using sildenafil attenuated HF-induced proinflammatory cytokine expression and the recruitment of macrophages into adipose tissue. Finally, we implicate a role for VASP, a downstream mediator of NO-cGMP signaling in mediating eNOS-induced antiinflammatory effects because VASPϪ/Ϫ mice recapitulated the proinflammatory phenotype displayed by eNOSϪ/Ϫ mice. Conclusion-These results imply a physiological role for endothelial NO to limit obesity-associated inflammation in adipose tissue and hence identify the NO-cGMP-VASP pathway as a potential therapeutic target in the treatment of diabetes. (Arterioscler Thromb Vasc Biol. 2011;31:2827-2835.)
O besity is linked to a state of chronic low-grade inflammation in adipose and other tissues that in turn contributes to insulin resistance and thereby predisposes to type-2 diabetes. At the cellular level, nutrient excess activates the inhibitor of nuclear factor kappa B kinase subunit ␤/nuclear factor-B (NF-B) pathway, a key mediator of inflammation in many cell types. 1 In visceral adipose tissue, this phenomenon is associated with infiltration of macrophages [2] [3] [4] that can impair insulin signaling through release of proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-␣ (TNF-␣). 5 Monocyte chemoattractant protein-1 (also known as CC chemokine ligand 2), produced by the adipose tissue in response to dietary overload, is believed to be crucial in recruiting macrophage precursors into the adipose tissue via interaction with its receptor, CC chemokine receptor 2 (CCR-2), on the surface of the monocytes. 5 Adipose tissue consists of adipocytes along with a stromal vascular fraction, the latter containing resident and infiltrating macrophages and an extensive network of vascular endothelial cells. In addition to transporting nutrients and adipokines, growing evidence suggests that the vasculature itself can actively influence tissue inflammation triggered by obesity. 6, 7 Among early responses observed in association with obesity-induced insulin resistance is a reduction of vascular nitric oxide (NO) content, an effect that precedes the onset of vascular and then peripheral tissue (such as liver, muscle, and adipose) inflammation and insulin resistance during dietary excess. 8 This observation raises the possibility that a diminished level of vascular NO may itself increase tissue susceptibility to the inflammatory effects of nutrient excess during high-fat (HF) feeding. Consistent with this hypothesis is a large body of literature documenting antiinflammatory effects of vascular NO. 7, 9 The enzyme endothelial nitric oxide synthase (eNOS) synthesizes NO from L-arginine and molecular oxygen in vascular tissues. 9 eNOS-derived NO induces vasodilatory, antiinflammatory, antithrombotic, and antiproliferative effects 7, 9 that may extend to surrounding nonvascular tissues. Although the role of eNOS-derived NO in adipose tissue has been studied with respect to its importance in mitochondrial biogenesis 10 and adipocyte differentiation, 11 it is not known whether reduced vascular NO signaling plays a role in obesity-associated adipose tissue inflammation.
Signal transduction induced by endothelial-derived NO involves activation of soluble guanylyl cyclase in vascular smooth muscle and many other cell types, thereby increasing cGMP production, which in turn activates the serinethreonine kinase cGMP-dependent protein kinase (PKG). Among several substrates for PKG action is vasodilatorstimulated phosphoprotein (VASP), which is phosphorylated by PKG on a specific serine residue (Ser-239). Although activation of VASP by PKG is implicated in several effects of NO-cGMP-PKG signaling, [12] [13] [14] whether VASP contributes to the antiinflammatory effects of this pathway has yet to be investigated.
Intracellular levels of cGMP are governed not only by guanylyl cyclase activity but also by phosphodiesterase conversion of cGMP back to GMP. Sildenafil is an inhibitor of phosphodiesterase type 5, which attenuates intracellular catabolism of cGMP and was shown previously to restrict vascular inflammation and insulin resistance in mice fed an HF diet. 15 In the current studies, we sought to investigate whether reduced vascular NO signaling contributes to development of obesity-associated adipose tissue inflammation. We found that HF feeding reduces biomarkers of vascular NO signaling in adipose tissue and that disruption of either eNOS or VASP signaling induces adipose tissue inflammation independent of diet. Combined with our finding that increased NOcGMP signaling induced by sildenafil attenuates adipose inflammation induced by HF feeding in normal mice, our findings implicate a physiological role for vascular NO signaling to restrain adipose tissue inflammation induced by nutrient excess.
Materials and Methods
Please see supplemental material, available online at http://atvb.ahajournals.org, for expanded Materials and Methods and Results sections.
Study Protocols
Adult male C57BL6 wild-type (WT) and eNOS -/-mice on a C57BL6 background were purchased from the Jackson Laboratory (Bar Harbor, ME). 15 VASP-deficient mice and their WT littermates were also bred onto the C57BL6 background. 12 Agematched groups (6 -12 weeks old) were maintained in a temperature-controlled facility with a 12-hour light-dark cycle and were fed ad libitum an equicaloric diet that was matched for micronutrient content that was either low (10% saturated fat) or high (60% saturated fat) in fat (Research Diets, New Brunswick, NJ, nos. D12492 and D12450B). In a separate study involving WT mice, sildenafil tablets (100 mg) were ground into a powder and mixed into a highly palatable "treat" containing peanut butter and an HF food pellet to deliver sildenafil orally at a dose of 30 mg/kg per day, as described previously. 15 At the conclusion of the protocol, animals were euthanized after an overnight fast, with an overdose of CO 2 followed by cervical dislocation. Epididymal adipose tissue was quickly removed and snap-frozen on dry ice and stored at Ϫ80°C until analysis. A portion of the epididymal fat tissue was collected in RNAlater (Ambion, Austin, TX) and stored at Ϫ20°C until RNA preparation. Protein was extracted from epididymal fat samples and quantified using a kit (Micro BCA Protein Assay Kit, Pierce, Rockford, IL). All procedures were approved by the University of Washington Institutional Animal Care and Use Committee.
Materials
Anti-phosphorylated eNOS (serine 1177), anti-phosphorylated p65-subunit of NF-B, anti-phosphorylated IB-␣, antiphosphorlylated-VASP Ser239, PKG, and ␤-actin antibodies were from Cell Signaling Technology (Beverly, MA); anti-eNOS antibody was obtained from Transduction Laboratories, BD Biosciences (Lexington, KY); Mac-2 antibody was from Cedarlane; and anti-GAPDH was from Santa Cruz Biotechnology.
Statistical Analysis
Statistical analysis was performed using the GraphPad Prism Version 5.0a (GraphPad Software Inc, La Jolla, CA 
Results

High-Fat Feeding Reduces eNOS and VASP Phosphorylation and Increases Inflammation in Adipose Tissue
Previous evidence indicates that in normal mice, HF feeding impedes the phosphorylation of eNOS (a marker of eNOS activation) in the thoracic aorta and that this effect is accompanied by reduced phosphorylation of Akt, 8 (the serine-threonine kinase that phosphorylates and thereby activates eNOS). Similarly, Akt phosphorylation was reduced and NF-B activation was increased in adipose tissue after 14 weeks of HF feeding. 8 Together, these observations suggest that reduced vascular NO signaling may contribute to adipose tissue inflammation during HF feeding. To test this hypothesis, we first determined the effect of HF feeding on phosphoeNOS content in epididymal white adipose tissue (EWAT). We found that in normal mice, HF feeding for 14 weeks (a time period known to increase NF-B signaling in EWAT 8 ) significantly decreased eNOS phosphorylation relative to total eNOS ( Figure 1A ). Total eNOS levels tended to decrease with HF feeding but did not reach statistical significance ( Figure 1A and Supplemental Figure IA) .
In vascular tissues, NO-cGMP activates PKG signaling, which leads to VASP phosphorylation at Ser239, an effect implicated in the vasodilatory function of NO. To examine the effect of HF feeding on the activation status of a downstream mediator of NO-cGMP signaling in EWAT, we measured levels of PKG and phospho-VASP. We found that compared with low-fat (LF)-fed controls, mice fed an HF diet for 14 weeks displayed reduced levels of both PKG and phospho-VASP in EWAT, suggesting a decrease in signaling through the vascular NO-PKG-VASP pathway ( Figure 1B and Supplemental Figure IB ). To further assess NO signaling in adipose tissue, basal NO levels were measured by the electron spin resonance spectroscopy technique, using the spin trap Fe(DETC) 2 as previously described. 8 An HF diet was associated with reduced adipose NO content ( Figure 1C ), consistent with decreased eNOS phosphorylation.
Combined with our finding of increased TNF-␣ mRNA content in the same EWAT samples ( Figure 1D ), these findings extend previous evidence that HF feeding induces NF-B activation in EWAT 8 and suggest that this effect is associated with reduced vascular NO content and signaling. We also observed an increase in levels of mac-2, a macrophage marker, in EWAT of mice fed an HF diet relative to LF-fed controls ( Figure 1E ), suggesting that HF feeding increases adipose tissue macrophage content, consistent with previous work. 16 
eNOS Deficiency Increases NF-B-Dependent Signaling in EWAT, Independently of Diet
To test whether the absence of eNOS mimics the effect of HF feeding in adipose tissue, we compared adipose tissue from eNOSϪ/Ϫ and WT mice after an LF and HF diet for 4 weeks. Importantly, the HF diet for 4 weeks does not induce NF-B activation in adipose tissue of WT mice. 8 Relative to WT controls, EWAT from eNOSϪ/Ϫ mice exhibited increased TNF-␣, IL-6, and monocyte chemoattractant protein-1 (MCP-1) mRNA expression ( Figure 2A ) and increased phosphorylation of p65 subunit of NF-B (Figure 2B ), despite showing no differences in body weight between the 2 groups. 15 Similarly, expression of mRNA encoding monocyte/macrophage/dendritic cell markers, such as CD68, F4/ 80, and CD11c, was increased in EWAT from eNOSϪ/Ϫ mice compared with WT mice (Figure 2A ). By comparison, M2 markers (arginase-1 and Ym-1, indicative of antiinflammatory macrophages) were not significantly different between WT and eNOSϪ/Ϫ mice irrespective of diet ( Figure  2A) , with the exception of IL-10, which showed a decrease in the HF-fed WT mice relative to LF. We also assessed mac-2 protein levels in the WT and eNOSϪ/Ϫ mice and found that, consistent with the increased mRNA expression of macrophage markers and inflammatory cytokines, mac-2 protein was increased in eNOSϪ/Ϫ mice relative to littermate controls ( Figure 2C ). These data collectively indicate that genetic eNOS deficiency mimics the effect of HF feeding to increase expression of proinflammatory cytokines and recruits macrophages to adipose tissue.
Effect of Sildenafil on HF-Induced Systemic Insulin Resistance
Because genetic absence of eNOS predisposes adipose tissue to inflammation, we sought to determine whether increased NO-cGMP signaling exerts a protective effect during HF feeding. To test this hypothesis in vivo, age-matched WT male mice were fed either an LF or an HF diet for 14 weeks, a period previously shown to cause both obesity and adipose tissue inflammation in mice. 8 During the last 4 weeks of the feeding protocol, mice in each diet group received a daily dose of either vehicle or sildenafil (30 mg/kg/d orally). Although the effect of HF feeding to raise fasting plasma glucose and insulin levels was attenuated by daily sildenafil treatment ( Figure 3B and 3C) , this intervention did not significantly alter body weight ( Figure 3A) . Thus, the beneficial effects of sildenafil in this model are not due to reduced weight gain. To better characterize glucose homeostasis in these mice, we performed insulin tolerance tests on a separate cohort of vehicle or sildenafil-treated mice fed the HF diet for 14 weeks. Compared with the vehicle-treated group, sildenafil treatment was associated with a greater insulin-mediated decrease of blood glucose, implying increased insulin sensitivity (Supplemental Figure IIA) . This pattern was evident regardless of whether insulin-induced decrease of plasma glucose was expressed in absolute terms or as the percentage change during the insulin tolerance test (Supplemental Figure IIB) . Thus, sildenafil appears to ameliorate systemic insulin resistance in mice fed an HF diet, as observed in an earlier study. 17 
Effect of Sildenafil on Adipose Tissue Inflammation in a Diet-Induced Model of Obesity
To confirm that sildenafil increased cGMP levels in adipose tissue, we performed Western blot analysis using an antibody that recognizes phospho-VASP at Ser239, because VASP phosphorylation correlates with cGMP levels. 18 As expected, sildenafil treatment restored phospho-VASP levels in HF EWAT, comparable to LF, demonstrating that sildenafil treatment improved NO-cGMP signaling in adipose tissue (Supplemental Figure III) .
As expected, 14 weeks of HF feeding was associated with increased NF-B signaling in adipose tissue, as assessed both by measuring levels of mRNA encoding MCP-1, TNF-␣, and IL-6 and by measures of inflammatory immune cells, such as CCR-2, CD68, F4/80, and CD11c ( Figure 4A ), and immunoblotting for phospho-IB-␣, a marker for NF-B activation ( Figure 4B ). Importantly each of these effects was attenuated by sildenafil treatment (Figure 4A and B). By comparison, HF feeding was associated with a decrease of M2 macrophage marker expression (arginase-1, Ym-1) in EWAT (Figure 4A) , and sildenafil treatment did not significantly alter this effect, suggesting that the protective action of sildenafil involves abolishing the recruitment of M1-activated macrophages rather than retention or recruitment of M2 macrophages. Consistent with these findings, immunoblot of protein lysates from high fat fed vehicle and sildenafil-treated mice using an antibody specific for mac-2 ( Figure 4C ) showed that levels of mac-2 in sildenafil-treated mice were reduced relative to controls. Thus, sildenafil treatment reduces adipose tissue macrophage infiltration and inflammation induced by HF feeding.
Effect of VASP on Adipose Tissue Inflammation
To test the hypothesis that VASP signaling is necessary for the antiinflammatory effects of NO-cGMP signaling on adipose inflammation, we used VASP-deficient and WT littermate mice fed an LF and HF diet for 4 weeks. As expected, in WT mice, 4 weeks of HF feeding was not associated with significant elevation in adipose inflammation compared with LF controls. On the other hand, we found that in EWAT from VASP-null mice, levels of mRNA encoding proinflammatory cytokines MCP-1, IL-6, and TNF-␣ were significantly elevated compared with WT controls, as was the phosphorylation of the p65 subunit of NF-B, indicative of increased NF-B activation ( Figure 5A and 5B). Furthermore, inflammatory myeloid markers such as CCR2, CD68, F4/80 and CD11c were also upregulated in EWAT from VASP-null mice compared with littermate controls. The expression of M2 macrophage markers (such as arginase-1 and IL-10 mRNA) showed no significant differences in the EWAT of VASPϪ/Ϫ mice relative to controls ( Figure 5A ). In addition, mac-2 protein levels were higher in the VASP null mice relative to controls ( Figure 5C ). Like eNOS deficiency, therefore, the absence of VASP mimics the effect of HF feeding to induce proinflammatory activation in adipose tissue.
Discussion
Overnutrition induces proinflammatory activation in adipose and many other tissues, and a growing body of evidence suggests that this response links obesity to insulin resistance and diabetes. 1 On the basis of evidence that endothelial nitric oxide signaling has antiinflammatory properties in the vasculature and that vascular nitric oxide levels decline early in the course of diet-induced obesity, we hypothesized an etiologic role for reduced vascular NO-cGMP signaling in the pathogenesis of adipose tissue inflammation and insulin resistance in diet-induced obesity. In this study, we found that in normal mice, HF feeding reduced vascular NO signaling in white adipose tissue in a manner that is temporally associated with adipose inflammation and insulin resistance. 8 Furthermore, genetic deficiency of eNOS induced adipose tissue inflammation even on an LF diet, suggesting that intact endothelial NO signaling limits inflammatory signaling in this tissue. Conversely, the deleterious inflammatory activation of adipose tissue induced by HF diet-measured in terms of both proinflammatory gene expression and adipose tissue macrophage accumulation-was prevented in WT mice by treatment with sildenafil, a drug that increases signaling downstream of vascular NO. This effect was accompanied by improved insulin sensitivity. Furthermore, we showed that deficiency of VASP, a downstream target of the NO-cGMP pathway, recapitulated the effect of eNOS deficiency to increase adipose tissue inflammation. Together, these results provide direct evidence in support of the hypothesis that vascular NO-cGMP signaling protects against adipose inflammation and that reduced eNOS/VASP function contributes to adipose tissue inflammation during HF feeding.
Adipose tissue is a complex endocrine organ composed of multiple cell types, including adipocytes, macrophages, and endothelial cells. In adipose tissue of lean animals, a healthy homeostasis exists among these cell types. HF feeding (or eNOS/VASP deletion) can disrupt this homeostasis by exerting proinflammatory effects that, in turn, promote macrophage recruitment into adipose tissue. Our finding that macrophage accumulation in adipose tissue is increased in mice lacking eNOS/VASP, even when fed an LF diet, whereas it is reduced by sildenafil treatment in HF-fed WT mice, suggests that obesity-induced macrophage influx requires a reduced NO signal.
Furthermore, in a severe model of obesity such as db/db mouse model, adipose tissue inflammation and macrophage infiltration are reduced by sildenafil (Supplemental Figure  VB and VC) . Sildenafil, however, did not reduce fasting insulin levels (data not shown) or reduce glucose levels (Supplemental Figure VA) . We recognize that the db/db mouse represents a severe form of diabetes and that restoration of leptin signaling is actually required for "normalization" of global metabolic parameters. 19 We speculate that sildenafil's effects are mainly limited to the NF-B pathway and sildenafil does not appear to "alter" the leptin signaling pathway.
In the vasculature, nitric oxide plays a crucial antiinflammatory role by regulating the expression of the chemokine MCP-1 20 and adhesion molecules, such as intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. These molecules are important for adhesion of monocytes to the vessel wall, initiating the first step of atherosclerosis. 7, 9 Consequently, mice lacking eNOS show increased expression of adhesion molecules and thereby exhibit increased leukocyte-endothelial interactions and diet-induced atherosclerosis. 9 Recent reviews have drawn parallels between the mechanisms regulating recruitment of monocytes to the artery wall and trafficking of macrophages to the adipose tissue suggesting that similar chemokine (MCP-1)/chemokine receptor (CCR-2) systems may be involved in both processes. 5, 21 This hypothesis is in agreement with our findings that decreased vascular NO/cGMP signaling leads to increased expression of MCP-1 and CCR-2 in the EWAT and consequent establishment of an inflammatory milieu in the adipose tissue.
The NO signaling cascade involves activation of soluble guanylyl cyclase, leading to the synthesis of cGMP, which, in turn activates the cGMP-dependent protein kinase (PKG). One of the targets of PKG is VASP, which plays an important role in cell migration and cytoskeletal dynamics. 14 PKG preferentially phosphorylates VASP at Ser239, and this effect is involved in the growth-inhibitory effects of NO on smooth muscle cells. 12 Downstream effects of VASP include regulation of actin polymerization and cell-cell contact in endothelial cells. 22 In a rodent model of diabetes, reduced phosphorylation of VASP at Ser239 correlates with insulin resistance, 13 but whether VASP signaling mediates the inhibitory effect of NO/cGMP on NF-B signaling had not been previously explored. Our finding that deficiency in VASP promotes proinflammatory M1 activation in the EWAT suggests that it plays an important role in antiinflammatory effects of vascular NO-cGMP signaling by attenuating NF-B signaling. However, based on our finding that VASP is expressed in several of the cell types present in adipose tissue, such as endothelial cells, macrophages, and adipocytes (data not shown), it is not possible to determine whether it is the vascular, myeloid, or adipocyte-specific VASP that is important for the antiinflammatory effects. Only a cell type specific ablation of VASP can definitively allow us to determine that. Activation of M2 phenotype has been associated with IL-4/STAT6 pathway 23 ; however, the association between VASP and M2 pathway has yet to be fully explored.
The interaction between NO and inflammation is complicated because at high levels, as generated by inducible NOS, NO is cytotoxic, relative to the much lower (nmol/L) levels produced by eNOS that activate the soluble guanylyl cyclase/ cGMP/PKG pathway, which are cytoprotective. 7 cGMP pools are regulated not only by guanylyl cyclase activity but also by the phosphodiesterase conversion of cGMP back to GMP. Sildenafil is a phosphodiesterase-5 inhibitor that inhibits this conversion. Sildenafil's effect in promoting signaling downstream of NO has been useful not only in treating erectile dysfunction but also in treating pulmonary hypertension and congestive heart failure. It may also augment ischemiainduced angiogenesis 24 and immune regulation. 25 Recent studies have established a connection between cGMP signaling and insulin action, wherein chronic sildenafil treatment leads to improved insulin sensitivity in mice fed a high-fat diet. 17 Furthermore, it attenuates endothelial dysfunctioninduced diabetes in rat 26 and humans. 27 Targeting phosphodiesterase-5 by using sildenafil circumvents the possible ill effects associated with excessive NO signaling, as produced by inducible NOS or as happens even when eNOS is overexpressed in apolipoprotein EϪ/Ϫ mice. 28 The deleterious effects associated with eNOS overexpression are explained by increased oxidative stress. 29 This potential pitfall can be avoided by targeting the downstream molecules in the NO-cGMP signaling pathway, such as activation of soluble guanylyl cyclase or PKG. Consistent with this, it was recently shown that overexpression of constitutively active PKG protects female mice from the ill effects of diet-induced obesity. 30 eNOS-derived NO appears to be crucial for the production of adequate endogenous levels of cGMP. In the absence of enhanced pools of cGMP, sildenafil was unable to exert anti-inflammatory effects. This was reflected in the lack of improved phosphorylation of VASP in eNOSϪ/Ϫ mice treated with sildenafil and no reduction in markers of adipose inflammation relative to controls (Supplemental Figure IV) . These observations allowed us to draw 2 important conclusions: (1) eNOS-derived NO-cGMP is critical for sildenafil's anti-inflammatory effects, and (2) phosphorylation of VASP in response to enhanced cGMP stores is required to exert protective effects of NO-cGMP. This suggests that VASP does not act independent of NO-cGMP, but needs enhanced cGMP signaling to alleviate adipose inflammation. These observations are consistent with the reports that sildenafil had no effect on erectile function in eNOSϪ/Ϫ mice. 31 Taken together, our findings support a model in which the effect of diet-induced obesity to reduce vascular NO-cGMP signaling contributes to the mechanism underlying adipose tissue inflammation. Therapeutic strategies designed to increase vascular NO/cGMP signaling may therefore be of value in prevention and treatment of obesity-associated diseases. Finally, in these studies, we show that deficiency of vascular nitric oxide primes the adipose tissue toward a proinflammatory state; that pharmacological improvement of NO-cGMP signaling reverses adipose inflammation during HF feeding; and that eNOSderived NO (and cGMP) is essential for VASP phosphorylation, which in turn is vital for sildenafil action, underlining the role of VASP as the effector of NO-cGMP signaling that limits adipose tissue inflammation.
